פגסיס 135 מק"ג/0.5 מ"ל

देश: इसराइल

भाषा: हिब्रू

स्रोत: Ministry of Health

सक्रिय संघटक:

PEGINTERFERON ALFA 2A 135 MCG / 0.5 ML

थमां उपलब्ध:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

ए.टी.सी कोड:

L03AB11

फार्मास्यूटिकल फॉर्म:

SOLUTION FOR INJECTION

प्रशासन का मार्ग:

S.C

द्वारा बनाया गया:

HOFFMANN LA ROCHE LTD, SWITZERLAND

चिकित्सीय समूह:

PEGINTERFERON ALFA-2A

चिकित्सीय संकेत:

Chronic Hepatitis B: Pegasys is indicated for the treatment of both HBeAg- positive and HBeAg -negative chronic hepatitis B in non-cirrhotic and cirrhotic adult patients with compensated liver disease and evidence of viral replication and liver inflammation.Chronic Hepatitis C: Pegasys is indicated for the treatment of chronic hepatitis C in adult patients who are positive for serum HCV-RNA including patients with compensated cirrhosis and/or co-infected with clinically stable HIV. The optimal way to use Pegasys in patients with chronic hepatitis C is in combination with ribavirin. The combination of Pegasys and ribavirin is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated ) alone or in combination therapy with ribavirin. Monotherapy is indicated mainly in case of intolerance or contraindication to ribavirin.

प्राधिकरण की तारीख:

2013-09-01